Daniel Bensen - Jun 7, 2024 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Jun 7, 2024
Transactions value $
-$74,045
Form type
4
Date filed
6/10/2024, 07:10 PM
Previous filing
Mar 13, 2024
Next filing
Aug 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Sale -$4K -200 -0.05% $20.00 431K Jun 7, 2024 Direct F1
transaction TYRA Common Stock Sale -$70K -3.5K -0.81% $20.00 428K Jun 10, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.